BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6229465)

  • 1. Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate.
    Adinolfi LE; Utili R; Gaeta GB; Abernathy CO; Zimmerman HJ
    Hepatology; 1984; 4(1):30-7. PubMed ID: 6229465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
    Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
    Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol-17 beta-(beta-D-glucuronide).
    Vore M; Durham S; Yeh S; Ganguly T
    Biochem Pharmacol; 1991 Feb; 41(3):431-7. PubMed ID: 1994901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats.
    Huang L; Smit JW; Meijer DK; Vore M
    Hepatology; 2000 Jul; 32(1):66-72. PubMed ID: 10869290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver.
    Liu Y; Huang L; Hoffman T; Gosland M; Vore M
    Cancer Res; 1996 Nov; 56(21):4992-7. PubMed ID: 8895755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of estradiol-17 beta-D-glucuronide-induced cholestasis by sodium tauroursodeoxycholate therapy in rats.
    Kinbara S; Ishizaki K; Sakakura H; Hirabayashi N; Kasai H; Araki T
    Scand J Gastroenterol; 1997 Sep; 32(9):947-52. PubMed ID: 9299676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver.
    Durham S; Vore M
    J Pharmacol Exp Ther; 1986 May; 237(2):490-5. PubMed ID: 3701641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17β-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C.
    Boaglio AC; Zucchetti AE; Sánchez Pozzi EJ; Pellegrino JM; Ochoa JE; Mottino AD; Vore M; Crocenzi FA; Roma MG
    Hepatology; 2010 Oct; 52(4):1465-76. PubMed ID: 20815017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca(2+)-dependent protein kinase C isoforms are critical to estradiol 17beta-D-glucuronide-induced cholestasis in the rat.
    Crocenzi FA; Sánchez Pozzi EJ; Ruiz ML; Zucchetti AE; Roma MG; Mottino AD; Vore M
    Hepatology; 2008 Dec; 48(6):1885-95. PubMed ID: 18972403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary secretion of glutathione in estradiol 17beta-D-glucuronide-induced cholestasis.
    Mottino AD; Veggi LM; Wood M; Román JM; Vore M
    J Pharmacol Exp Ther; 2003 Oct; 307(1):306-13. PubMed ID: 12893835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of 3H-estradiol-17 beta-(beta-D-glucuronide), a cholestatic organic anion, to rat liver plasma membranes. Evidence consonant with identification of organic anion carriers.
    Takacs AL; Vore M
    Mol Pharmacol; 1987 Oct; 32(4):511-8. PubMed ID: 3670282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK1/2 and p38 MAPKs are complementarily involved in estradiol 17ß-D-glucuronide-induced cholestasis: crosstalk with cPKC and PI3K.
    Boaglio AC; Zucchetti AE; Toledo FD; Barosso IR; Sánchez Pozzi EJ; Crocenzi FA; Roma MG
    PLoS One; 2012; 7(11):e49255. PubMed ID: 23166621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the interaction between estrogen metabolites and taurocholate for uptake into isolated hepatocytes. Lack of correlation between cholestasis and inhibition of taurocholate uptake.
    Brock WJ; Durham S; Vore M
    J Steroid Biochem; 1984 May; 20(5):1181-5. PubMed ID: 6727367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple carriers for uptake of [3H]estradiol-17 beta(beta-D-glucuronide) in isolated rat hepatocytes.
    Brouwer KL; Durham S; Vore M
    Mol Pharmacol; 1987 Oct; 32(4):519-23. PubMed ID: 3670283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. 1. Effects of lithocholic, 3beta-hydroxy-5-cholenoic, cholic, and dehydrocholic acids.
    Miyai K; Richardson AL; Mayr W; Javitt NB
    Lab Invest; 1977 Mar; 36(3):249-58. PubMed ID: 839737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of estradiol 17 beta-D-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat.
    Alvaro D; Angelico M; Cantafora A; Gaudio E; Gandin C; Santini MT; Masella R; Capocaccia L
    Hepatology; 1991 Jun; 13(6):1158-72. PubMed ID: 1646761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microtubules in estradiol-17beta-D-glucuronide-induced alteration of canalicular Mrp2 localization and activity.
    Mottino AD; Crocenzi FA; Pozzi EJ; Veggi LM; Roma MG; Vore M
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G327-36. PubMed ID: 15374814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of uptake of steroid glucuronides into isolated male and female rat hepatocytes.
    Brock WJ; Vore M
    J Pharmacol Exp Ther; 1984 Apr; 229(1):175-81. PubMed ID: 6707932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of function and localization of tight junctional structures and Mrp2 in sustained estradiol-17beta-D-glucuronide-induced cholestasis.
    Mottino AD; Hoffman T; Crocenzi FA; Sánchez Pozzi EJ; Roma MG; Vore M
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G391-402. PubMed ID: 17463180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirex exposure inhibits the uptake of estradiol-17 beta(beta-D-glucuronide), taurocholate, and L-alanine into isolated rat hepatocytes.
    Teo S; Vore M
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):411-20. PubMed ID: 1696754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.